CBH Health, LLC

Rockville, Maryland 20850

0 studies enrolling now · 12 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Central Nervous System Diseases, Cognition, Schizoaffective Disorder, Schizophrenia

Studies at this site

• An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia — Completed
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease — Completed
• Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease — Completed
• Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease — Completed
• An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia — Stopped early
• PEARL Schizophrenia Maintenance — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• Bioavailability of LY03004 and Risperdal® Consta® — Completed
• Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients — Completed